XORTX Therapeutics : CONSOLIDATED FINANCIAL STATEMENTS - Form 6-K -April 04, 2024 at 06:04 am EDT
CONSOLIDATED FINANCIAL STATEMENTS AS AT AND FOR THE YEARS ENDED DECEMBER 31, 2023, 2022 and 2021 REPORT OF INDEPENDENT REGISTERED PUBLIC...
Stay updated with breaking news from Amar Keshri. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CONSOLIDATED FINANCIAL STATEMENTS AS AT AND FOR THE YEARS ENDED DECEMBER 31, 2023, 2022 and 2021 REPORT OF INDEPENDENT REGISTERED PUBLIC...
CALGARY, Alberta, Aug. 04, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on
CALGARY, Alberta, Jan. 31, 2022 -- XORTX Therapeutics Inc. , a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, is pleased to... | January 31, 2022
GuruFocus Article or News written by GuruFocusNews and the topic is about: